Radiopharmaceuticals for Skeletal Muscle PET Imaging

Joo Yeon Park,Sun Mi Park,Tae Sup Lee,Seo Young Kang,Ji-Young Kim,Hai-Jeon Yoon,Bom Sahn Kim,Byung Seok Moon
DOI: https://doi.org/10.3390/ijms25094860
IF: 5.6
2024-04-30
International Journal of Molecular Sciences
Abstract:The skeletal muscles account for approximately 40% of the body weight and are crucial in movement, nutrient absorption, and energy metabolism. Muscle loss and decline in function cause a decrease in the quality of life of patients and the elderly, leading to complications that require early diagnosis. Positron emission tomography/computed tomography (PET/CT) offers non-invasive, high-resolution visualization of tissues. It has emerged as a promising alternative to invasive diagnostic methods and is attracting attention as a tool for assessing muscle function and imaging muscle diseases. Effective imaging of muscle function and pathology relies on appropriate radiopharmaceuticals that target key aspects of muscle metabolism, such as glucose uptake, adenosine triphosphate (ATP) production, and the oxidation of fat and carbohydrates. In this review, we describe how [18F]fluoro-2-deoxy-D-glucose ([18F]FDG), [18F]fluorocholine ([18F]FCH), [11C]acetate, and [15O]water ([15O]H2O) are suitable radiopharmaceuticals for diagnostic imaging of skeletal muscles.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?